Success Story: EB2 NIW Approval for a Researcher in the field of Biochemistry in 6 weeks

Client’s Testimonial: 

Congratulations for the job well done. I went to the immigration website to checked I-140 status. It has been approved. I am waiting for the letter. Thanks a lot for your help. Have a great day!

 


On May 6th, 2013, we received another EB2 NIW (National Interest Waiver) Approval for a Researcher in the field of Biochemistry (Approval Notice)


General Field: Biochemistry Position at the Time of Case Filing: Researcher National Origin: Nigeria Service Center: Texas Service Center (TSC) State Residing at the Time of Filing: Florida Approval Notice Date: May 6, 2013 Processing Time: 6 weeks


Case Summary:

This client’s previous attorney suggested that she file under EB1-A category, which has the highest standard of law. The EB1-A case was denied and we were approached by the client regarding the appeal process. Given that the client was not born in India or China and the priority date was current under EB-2 category, we correctly suggested that the client file under EB-2 NIW (National Interest Waiver) and the case was approved in six weeks.

This client is a researcher from Nigeria in the field of biochemistry. She has focused most of her work specifically on innovative treatments for cancer, care for arthritis, joint health, cardiovascular diseases, and utilizing proteomics to study biomarkers and signaling pathways in order to develop these new treatment technologies. She wished to seek employment in the field of biochemistry, particularly as it relates to cancer and arthritis. To ensure successful approval of this case, we submitted extensive documentation of the client’s highly significant contributions to the field of biochemistry, including her authorship of 14 peer-reviewed scientific articles in leading journals, and 36 peer-reviewed published proceedings and conference articles. Additionally, our firm drafted and submitted several recommendation letters from experts in our client’s shared field. One of the independent recommenders noted “[The Petitioner’s] technique allows scientists to accurately measure the concentration of proteins even in very small fluid or tissue samples. It is a great improvement upon previously sanctioned methods, which required larger samples and exhibited lower accuracy. Her method is already in use in the research of diseases ranging from other cancers to arthritis to neurological diseases . . .”  With the strong petition letter and recommendation letters we prepared, her NIW case was approved in just six weeks.